cancer detection

Investigates the genetic and biochemical changes that cause cancer.
Significant breakthroughs since 1980 have improved cancer research, leading to hopes for better diagnostics and treatments.

Success rates for cancer treatment are highly influenced by when the disease is diagnosed.
Early detection often leads to high cure rates, even for cancers with poor prognoses.
Many cancers develop slowly, providing a window of opportunity for early detection.

Cancers often display few symptoms in their early stages, complicating early diagnosis.
The American Cancer Society identified seven warning signs:
1. Change in bowel or bladder habits.
2. A sore that does not heal.
3. Unusual bleeding or discharge.
4. Thickening or lump in the breast or elsewhere.
5. Indigestion or difficulty swallowing.
6. Obvious change in a wart or mole.
7. Nagging cough or hoarseness.
These symptoms might not appear until the later stages of cancer.

Pap Smear: Used for cervical cancer detection; allows examination of cells for abnormalities before invasion.
Mammography: Utilizes low-dose X-rays to identify early-stage breast cancer; requires biopsy for confirmation.
Colonoscopy & FOBT: For colorectal cancer detection; various tests available for different types of cancer.
PSA Test: Blood test for prostate cancer.
Emerging Techniques: Proteomic analysis showing promise for detecting cancers using blood samples.

A definitive cancer diagnosis usually requires a biopsy to examine tissue for malignancy.
Imaging techniques (e.g., CT scans, MRIs) assist in identifying the location and extent of tumors before biopsy.

Staging assesses tumor size, spread to lymph nodes, and distant metastasis.
Grading evaluates cellular and tissue characteristics used to predict prognosis and treatment strategies.

Primary method to cure localized cancers before metastasis.
Different techniques, including traditional surgical methods, laser surgery, and cryosurgery, are employed based on tumor location.

Uses high-energy radiation to kill cancer cells or induce apoptosis, focusing on tumors while protecting normal tissue as much as possible.
Administered in divided doses to minimize damage to surrounding healthy tissues.

Involves using drugs that target cancer cells throughout the body via bloodstream.
Major categories:
1. Antimetabolites: Interfere with DNA synthesis.
2. Alkylating Agents: Crosslink DNA.
3. Antibiotics: Bind DNA or inhibit replication enzymes.
4. Plant-based Drugs: Target mitotic spindle.
Drug resistance is a significant hurdle, leading to treatment failure in some patients.

Exploits the immune system's ability to recognize and destroy cancer cells using:
- Cytokines: Stimulate immune activity.
- Monoclonal Antibodies: Specifically target cancer cell receptors.
- Vaccines: Aim to elicit a strong immune response against tumor-associated antigens.

Involves developing drugs that specifically target proteins vital to cancer cell proliferation, such as:
- Herceptin: Targets overexpressed Her2 receptors in breast cancer.
- Gleevec: Inhibits the Bcr-Abl oncogene in chronic myelogenous leukemia.

Targets blood vessel growth essential for tumor nutrition; includes medications that inhibit angiogenesis molecules.
Shows promise with fewer side effects than traditional treatments.

Aims to correct defective genes responsible for cancer; involves the delivery of normal genes or engineered viruses to selectively kill cancer cells.

New drugs undergo multi-phase clinical trials, typically taking 5-10 years and costing millions before FDA approval.
Phases include initial safety (Phase I), effectiveness (Phase II), and comprehensive testing (Phase III).

Many patients explore complementary and alternative therapies often lacking scientific support, which can pose health risks if they replace proven treatments.
Examples include successful herbal treatments being adulterated with synthetic substances.

Psychological states, such as stress and depression, may impact cancer but are not direct causes.
Support groups and psychological interventions may improve quality of life but evidence for improving survival remains inconclusive.

Advances in cancer biology have led to improved screening, diagnosis, and treatment methods, though challenges such as drug resistance and psychological factors continue to complicate patient outcomes.